How do I transfer my HER2-Positive Breast Cancer care to another hospital

Transferring Your HER2-Positive Breast Cancer Care to Another Hospital

I understand you're considering moving your care—this is an important decision for HER2-positive breast cancer, where specialized expertise and access to the latest treatment options can significantly impact your outcomes. Let me walk you through the practical steps and what to consider.

Why Transfer Care?

According to the CancerPatientLab webinars on patient navigation, patients often seek transfers to different institutions for several valid reasons:

• Access to clinical trials - Major cancer centers have more trials available, especially for advanced HER2-positive disease
• Specialized expertise - Some centers have deeper experience with HER2-targeted therapies
• Second opinions - Getting comprehensive review of your specific case
• Better treatment options - Access to newer drugs like Enhertu (trastuzumab deruxtecan) or novel combinations

Step-by-Step Transfer Process

1. **Gather Your Complete [ID removed]

Request ALL documentation from your current hospital:

• Pathology report (including HER2 testing results and methodology)
• Imaging studies (scans, mammograms) - request the actual images, not just reports
• Treatment history and response assessments
• Lab work and biomarker testing
• Genetic testing results (BRCA1/BRCA2 if done)
• Any genomic or molecular profiling reports

Important tip from patient advocates: Request "underlying data that informs results," not just summaries. For example, if you had immunohistochemistry (IHC) staining for HER2, ask for the actual images and detailed measurements, not just a conclusion.

2. Choose Your New Hospital

For HER2-positive breast cancer, consider major cancer centers with:

• Dedicated breast cancer programs
• Active clinical trials for HER2-positive disease
• Multidisciplinary teams (medical oncologist, surgeon, radiation oncologist, pathologist)
• Access to precision medicine testing

According to expert guidance, institutions like MD Anderson, Sloan Kettering, Mount Sinai, Johns Hopkins, Fred Hutchinson, and UCSF typically have extensive trial access and specialists who "think outside the box" for complex cases.

3. Request a Formal Transfer

Contact your new hospital's oncology department and:

• Request a consultation or second opinion appointment
• Explain you're considering transferring your full care
• Ask about their HER2-positive breast cancer treatment approach
• Inquire about clinical trial availability for your specific situation

4. Facilitate Communication Between Institutions

This is critical. According to patient advocacy experts:

Don't rely on electronic requests alone. Ask your current doctor to call the referring physician directly at the new hospital. This ensures:

• Your case is properly understood
• Important nuances aren't lost in translation
• Faster coordination of care
• Better continuity

5. Transfer Your Tissue Samples

For HER2-positive breast cancer, your tumor tissue is valuable for:

• Confirming HER2 status with current testing methods
• Additional molecular profiling (genomic sequencing, proteomic testing)
• Potential future testing as new biomarkers emerge

Request that your pathology samples be transferred to the new institution's pathology department.

What to Bring to Your First Appointment

• All imaging on CD/USB (actual images, not just reports)
• Pathology report with HER2 testing details
• Treatment records with specific drug names, doses, and dates
• Response assessments (how your cancer responded to each treatment)
• Any genomic testing reports
• List of current medications and side effects experienced
• Questions written down

Important Considerations for HER2-Positive Breast Cancer

HER2 protein expression matters. According to proteomics research, HER2 levels above 750 amol per microgram indicate over-expression, which typically opens up dual anti-HER2 therapy options (like pertuzumab and trastuzumab together). Make sure your new team:

• Understands your specific HER2 expression level
• Reviews whether you've had dual anti-HER2 therapy
• Considers newer options like Enhertu if you've progressed on standard therapies

Questions to Ask Your New Care Team

1. "What is your standard treatment approach for HER2-positive breast cancer at my stage?"
2. "What clinical trials are currently open for patients with my HER2 status and treatment history?"
3. "Do you recommend any additional testing (genomic sequencing, liquid biopsy, immune profiling) to guide treatment?"
4. "If I progress on current therapy, what are the next treatment options you would consider?"
5. "How will you monitor my response to treatment—what imaging schedule and measurements will you use?"

Accessing Second Opinions (Free Resources)

Before or during your transfer, consider getting expert review:

• Cancer Commons - Offers free second opinion services
• Cincinnati Cancer Advisors - Free second opinions (if in eligible states)
• Academic medical centers often have formal second opinion programs

Timeline Expectations

A typical transfer visit at a major cancer center:

• Initial consultation: 1-2 days (blood work, meet with oncologist, possibly other specialists)
• Decision-making: Your new team will review all records and discuss recommendations
• Ongoing care: Can often be coordinated locally if the same trial exists at a closer institution

Important Reminder

According to Dr. [removed] Lopez-Correa, an MD/PhD who navigated her own breast cancer diagnosis: "Not all tests are standard of care, so you may need to challenge healthcare providers and push for additional testing." If your new team doesn't offer comprehensive genomic analysis or molecular profiling, ask why—these tests can reveal actionable mutations that guide treatment selection.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.